Boehme, V <br/><br/>
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Jan 2007 
 - 149-157 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0923-7534 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdl327  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Brain Neoplasms--drug therapy<br/>Cyclophosphamide--therapeutic use<br/>Doxorubicin--therapeutic use<br/>Etoposide--therapeutic use<br/>Female<br/>Health Surveys<br/>Humans<br/>Incidence<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Prednisolone--therapeutic use<br/>Prednisone--therapeutic use<br/>Risk Factors<br/>Survival Rate<br/>Vincristine--therapeutic use